Therapeutic Effects of Suppressors of Cytokine Signaling in Diabetic Nephropathy

Journal of Histochemistry and Cytochemistry

Volumn 62, Issue 2, 2014, Pages 119-128

  Liu, Qingjuan ^a   Xing, Lingling ^a   Wang, Lei ^a   Yao, Fang ^a   Liu, Shuxia ^a   Hao, Jun ^a   Liu, Wei ^a   Duan, Huijun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

diabetic nephropathy; epithelial myofibroblast transdifferentiation; oncostatin M; SOCS

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; JANUS KINASE; ONCOSTATIN M; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD-1 MOUSE; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENE OVEREXPRESSION; GENE TRANSFER; INTRACELLULAR SIGNALING; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; THERAPY EFFECT; TUBULAR EPITHELIAL CELL MYOFIBROBLAST TRANSDIFFERENTIATION;

DIABETIC NEPHROPATHY; EPITHELIAL-MYOFIBROBLAST TRANSDIFFERENTIATION; ONCOSTATIN M; SOCS;

ACTINS; ANIMALS; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROSIS; GENETIC THERAPY; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; MICE; ONCOSTATIN M; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84893100548     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155413512493     Document Type: Article

References (33)

1. Adhikari N,Charles N,Lehmann U,Hall JL.Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury.Curr Atheroscler Rep. 2006;8:252-260.
2. Badid C,Desmouliere A,Babici D,Hadj-Aissa A,McGregor B,Lefrancois N,Touraine JL,Laville M.Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction.Nephrol Dial Transplant. 2002;17:1993-1998.
3. Berthier CC,Zhang H,Schin M,Henger A,Nelson RG,Yee B,Boucherot A,Neusser MA,Cohen CD,Carter-Su C,Argetsinger LS,Rastaldi MP,Brosius FC,Kretzler M.Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.Diabetes. 2009;58:469-477.
4. Bohle A,Mackensen-Haen S,von Gise H.Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution.Am J Nephrol. 1987;7:421-433.
5. Dalla Vestra M,Mussap M,Gallina P,Bruseqhin M,Cernigoi AM,Saller A,Plebani M,Fioretto P.Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.J Am Soc Nephrol. 2005;16:S78-S82.
6. Doerner AM,Zuraw BL.TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids.Respir Res. 2009;10:100-114.
7. Elbjeirami WM,Truong LD,Tawil A,Wang W,Dawson S,Lan HY,Zhang P,Garcia GE,Wayne Smith C.Early differential expression of oncostatin M in obstructive nephropathy.J Interferon Cytokine Res. 2010;30:513-523.
8. Fan JM,Huang XR,Ng YY,Nikolic-Paterson DJ,Mu W,Atkins RC,Lan HY.Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.Am J Kidney Dis. 2001;37:820-831.
9. Galkina E,Ley K.Leukocyte recruitment and vascular injury in diabetic nephropathy.J Am Soc Nephro. 2006;17:368-377.
10. Gómez-Guerrero C,López-Franco O,Sanjuán G,Hernández-Vargas P,Suzuki Y,Ortiz-Muñoz G,Blanco J,Egido J.Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury.J Immunol. 2004;172:6969-6977.
11. Hernández-Vargas P,López-Franco O,Sanjuán G,Rupérez M,Ortiz-Muñoz G,Suzuki Y,Aguado-Roncero P,Pérez-Tejerizo G,Blanco J,Egido J,Ruiz-Ortega M,Gómez-Guerrero C.Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.J Am Soc Nephrol. 2005;16:1673-1683.
12. Humphreys BD,Lin SL,Kobayashi A,Hudson TE,Nowlin BT,Bonventre JV,Valerius MT,McMahon AP,Duffield JS.Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.Am J Pathol. 2010;176:85-97.
13. Idasiak-Piechocka I,Krzymański M.The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN).Przegl Lek. 1996;53:443-453.
14. Kamitani S,Yamauchi Y,Kawasaki S,Takami K,Takizawa H,Nagase T,Kohyama T.Simultaneous stimulation with TGF-β1 and TNF-α induces epithelial mesenchymal transition in bronchial epithelial cells.Int Arch Allergy Immuno. 2011;155:119-128.
15. Lim AK,Tesch GH.Inflammation in diabetic nephropathy.Mediators Inflamm. 2012;:146154.
16. Liu Q,Liu S,Shi Y,Li H,Hao J,Xing L,Cao Y,Duan H.Suppressors of cytokine signaling inhibit tubular epithelial cell-myofibroblast transdifferentiation.Am J Nephrol. 2011;34:142-151.
17. Mensah-Brown EP,Obineche EN,Galadari S,Chandranath E,Shahin A,Ahmed I,Patel SM,Adem A.Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines.Cytokine. 2005;31:180-190.
18. Meyer TW.Tubular injury in glomerular disease.Kidney Int. 2003;63:774-787.
19. Iwano M,Plieth D,Danoff TM,Xue C,Okada H,Neilson EG.Evidence that fibroblasts derive from epithelium during tissue fibrosis.J Clin Invest. 2002;110:341-350.
20. Navarro JF,Milena FJ,Mora C,León C,García J.Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.Am J Nephrol. 2007;26:562-570.
21. Navarro JF,Mora C,Muros M,García J.Urinary tumour necrosis factor-α excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.Nephrol Dial Transplant. 2006;21:3428-3434.
22. Nightingale J,Patel S,Suzuki N,Buxton R,Takagi KI,Suzuki J,Sumi Y,Imaizumi A,Mason RM,Zhang Z.Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation.J Am Soc Nephrol. 2004;15:21-32.
23. Okoń K.Tubulo-interstitial changes in glomerulopathy. II. Prognostic significance.Pol J Pathol. 2003;54:163-169.
24. Ortiz-Muñoz G,Lopez-Parra V,Lopez-Franco O,Fernandez-Vizarra P,Mallavia B,Flores C,Sanz A,Blanco J,Mezzano S,Ortiz A,Eqido J,Gomez-Guerrero C.Suppressors of cytokine signaling abrogate diabetic nephropathy.J Am Soc Nephrol. 2010;21:763-772.
25. Pollack V,Sarközi R,Banki Z,Feifel E,Wehn S,Gstraunthaler G,Stoiber H,Mayer G,Montesano R,Strutz F,Schramek H.Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling.Am J Physiol Renal Physiol. 2007;293:F1714-1726.
26. Rubio-Guerra AF,Vargas-Robles H,Lozano Nuevo JJ,Escalante-Acosta BA.Correlation between circulating adhesion molecule levels and albuminuria in type-2 diabetic hypertensive patients.Kidney Blood Press Res. 2009;32:106-109.
27. Rui L,Yuan M,Frantz D,Shoelson S,White MF.SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.J Biol Chem. 2002;277:42394-42398.
28. Sarközi R,Hauser C,Noppert SJ,Kronbichler A,Pirklbauer M,Haller VM,Grillari J,Grillari-Voglauer R,Mayer G,Schramek H.Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression.Am J Physiol Renal Physiol. 2011;301:F1014-1025.
29. Shi Y,Du C,Zhang Y,Ren Y,Hao J,Zhao S,Yao F,Duan H.Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy.Am J Nephrol. 2010;31:380-388.
30. Shouda T,Yoshida T,Hanada T,Wakioka T,Oishi M,Miyoshi K,Komiya S,Kosai K,Hanakawa Y,Hashimoto K,Nagata K,Yoshimura A.Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.J Clin Invest. 2001;108:1781-1788.
31. Tuttle KR.Linking Metabolism and Immunology: Diabetic Nephropathy Is an Inflammation Disease.J Am Soc Nephrol. 2005;16:1537-1538.
32. Wang F,Li M,Cheng L,Zhang T,Hu J,Cao M,Zhao J,Guo R,Gao L,Zhang X.Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.Life Sci. 2008;83:828-835.
33. Yoshimura A,Naka T,Kubo M.SOCS proteins, cytokine signaling and immune regulation.Nat Rev Immunol. 2007;7:454-465.